Abstracts

ORAL PrEP USE AMONG SOUTH AFRICAN WOMEN WITH PLANS FOR PREGNANCY

Women exposed to HIV need strategies to mitigate periconception HIV acquisition. We evaluated longitudinal use of TDF/FTC as PrEP among HIV-uninfected women with personal or partner plans for pregnancy in Durban, South Africa. We enrolled HIV-uninfected women, aged 18-35 years, reporting personal or partner plans for pregnancy, and a partner with HIV or of unknown-serostatus.…

EXTENDED-RELEASE NALTREXONE LOWERS INJECTION USE IN JUSTICE-INVOLVED PERSONS WITH HIV

Opioid use disorder (OUD) and injection drug use (IDU) behavior are both highly prevalent among justice involved individuals, with the latter increasing risk for HIV acquisition. Medications for opioid use disorder (MOUD), including extended-release naltrexone (XR-NTX), are associated with increased retention on antiretroviral therapy (ART) and viral suppression in persons with HIV (PWH). However, the…